Urologic Neoplasms

"Urologic Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Tumors or cancer of the URINARY TRACT in either the male or the female.

Descriptor ID	D014571
MeSH Number(s)	C04.588.945.947 C12.758.820 C13.351.937.820
Concept/Terms	Urologic Neoplasms Urologic Neoplasms Urological Neoplasms Neoplasm, Urological Neoplasms, Urological Urological Neoplasm Urinary Tract Neoplasms Neoplasm, Urinary Tract Neoplasms, Urinary Tract Tract Neoplasm, Urinary Tract Neoplasms, Urinary Urinary Tract Neoplasm Neoplasms, Urologic Neoplasm, Urologic Urologic Neoplasm Cancer of Urinary Tract Cancer of Urinary Tract Urinary Tract Cancers Urological Cancer Cancer, Urological Cancers, Urological Urological Cancers Cancer of the Urinary Tract Urinary Tract Cancer Cancer, Urinary Tract Cancers, Urinary Tract Urologic Cancer Cancer, Urologic Cancers, Urologic Urologic Cancers

Below are MeSH descriptors whose meaning is more general than "Urologic Neoplasms".

Diseases [C]
Neoplasms [C04]
Neoplasms by Site [C04.588]
Urogenital Neoplasms [C04.588.945]
Urologic Neoplasms [C04.588.945.947]
Male Urogenital Diseases [C12]
Urogenital Neoplasms [C12.758]
Urologic Neoplasms [C12.758.820]
Female Urogenital Diseases and Pregnancy Complications [C13]
Female Urogenital Diseases [C13.351]
Urogenital Neoplasms [C13.351.937]
Urologic Neoplasms [C13.351.937.820]

Below are MeSH descriptors whose meaning is related to "Urologic Neoplasms".

Below are MeSH descriptors whose meaning is more specific than "Urologic Neoplasms".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Urologic Neoplasms" by people in this website by year, and whether "Urologic Neoplasms" was a major or minor topic of these publications.

Bar chart showing 57 publications over 22 distinct years, with a maximum of 10 publications in 2024

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	3	0	3
1998	2	0	2
2000	2	0	2
2001	1	0	1
2002	2	0	2
2007	2	0	2
2008	1	0	1
2010	1	0	1
2011	1	0	1
2012	1	0	1
2014	1	0	1
2015	1	0	1
2016	6	0	6
2017	3	0	3
2018	4	0	4
2019	2	0	2
2020	8	1	9
2021	2	0	2
2022	1	0	1
2023	1	0	1
2024	7	3	10
2025	1	0	1

Below are the most recent publications written about "Urologic Neoplasms" by people in Profiles.

Zarrabi KK, Saxena A, Mouw KW, Koshkin VS, Friedlander T. Unmet Potential of Antibody-Drug Conjugates: An Evaluation of the Past, Present, and Future of Antibody-Drug Conjugate Development in Advanced Urothelial Carcinoma. Am Soc Clin Oncol Educ Book. 2025 Jan; 45(2):e471924.

View in: PubMed
Vlachou E, Hoffman-Censits J, Singla N. The biologic landscape and therapeutic implications of upper tract urothelial cancer. Curr Opin Urol. 2025 01 01; 35(1):89-95.

View in: PubMed
Shah YB, Ghosh A, Hochberg A, Mark JR, Lallas CD, Shah MS. Artificial intelligence improves urologic oncology patient education and counseling. Can J Urol. 2024 Oct; 31(5):12013-12018.

View in: PubMed
Apolo AB, Ballman KV, Sonpavde G, Berg S, Kim WY, Parikh R, Teo MY, Sweis RF, Geynisman DM, Grivas P, Chatta G, Reichert ZR, Kim JW, Bilen MA, McGregor B, Singh P, Tripathi A, Cole S, Simon N, Niglio S, Ley L, Cordes L, Srinivas S, Huang J, Odegaard M, Watt C, Petrylak D, Hoffman-Censits J, Wen Y, Hahn O, Mitchell C, Tan A, Streicher H, Sharon E, Moon H, Woods M, Halabi S, Perez Burbano G, Morris MJ, Rosenberg JE. Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma. N Engl J Med. 2025 Jan 02; 392(1):45-55.

View in: PubMed
Vlachou E, Johnson ? BA, Guancial E, Lombardo KA, Hoffman-Censits J. Frontline immune checkpoint inhibitors in patients = 90 years with advanced urothelial cancer: a single center experience. Can J Urol. 2024 Jun; 31(3):11875-11879.

View in: PubMed
Eturi A, Bhasin A, Zarrabi KK, Tester WJ. Predictive and Prognostic Biomarkers and Tumor Antigens for Targeted Therapy in Urothelial Carcinoma. Molecules. 2024 Apr 22; 29(8).

View in: PubMed
Powles T, Valderrama BP, Gupta S, Bedke J, Kikuchi E, Hoffman-Censits J, Iyer G, Vulsteke C, Park SH, Shin SJ, Castellano D, Fornarini G, Li JR, G?m?s M, Mar N, Loriot Y, Fl?chon A, Duran I, Drakaki A, Narayanan S, Yu X, Gorla S, Homet Moreno B, van der Heijden MS. Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer. N Engl J Med. 2024 03 07; 390(10):875-888.

View in: PubMed
Grajales V, Martini A, Shore ND. Complications of immuno-oncology care: what urologist should know. BJU Int. 2024 05; 133(5):524-531.

View in: PubMed
Fletcher SA, Pallauf M, Watts EK, Lombardo KA, Campbell JA, Rezaee ME, Roupr?t M, Boorjian SA, Potretzke AM, Roshandel MR, Ploussard G, Djaladat H, Ghoreifi A, Mari A, Campi R, Khene ZE, Raman JD, Kikuchi E, Rink M, Abdollah F, Boormans JL, Fujita K, D'Andrea D, Soria F, Breda A, Hoffman-Censits J, McConkey DJ, Shariat SF, Pradere B, Singla N. Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant Chemotherapy. Eur Urol Oncol. 2024 Oct; 7(5):1061-1068.

View in: PubMed
Oldan JD, Schroeder JA, Hoffman-Censits J, Rathmell WK, Milowsky MI, Solnes LB, Nimmagadda S, Gorin MA, Khandani AH, Rowe SP. PET/Computed Tomography Transformation of Oncology: Kidney and Urinary Tract Cancers. PET Clin. 2024 Apr; 19(2):197-206.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement